Ultrasound for Detection of Prostate Cancer
Not Applicable
Completed
- Conditions
- Prostate Cancer
- Interventions
- Device: SURF
- Registration Number
- NCT05736094
- Lead Sponsor
- Oslo University Hospital
- Brief Summary
Clinical proof of concept of dual-frequency ultrasound imaging for detection and visualization of prostate cancer.
- Detailed Description
Prospectively recruited patients before prostatectomy and/or definitive radiotherapy will be included in the study. Dual-frequency ultrasound imaging will be compared to standard transrectal ultrasound and MRI. Imaging of primary tumor with dual-frequency ultrasound technology including the use of microbubble contrast-media.
A prostate biopsy and blood sample will be taken from each patient, for histopathology and explorative biomarkers.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Male
- Target Recruitment
- 11
Inclusion Criteria
- Age 18 years onwards
- Signed written informed consent to perform rectal and transperineal ultrasound
Exclusion Criteria
- N/A
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Dual-frequency ultrasound SURF Dual-frequency ultrasound for detection of prostate cancer
- Primary Outcome Measures
Name Time Method Clinical proof of concept of dual-frequency ultrasound imaging for detection and visualization of prostate cancer. 1 day Comparing dual-frequency ultrasound, shear waves ultrasound, CEUS to MRI and histopathological findings
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Oslo University Hospital
🇳🇴Oslo, Norway